KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Enterprise Value Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 3.60%
Dec 28, 2025 3.37%
Sep 28, 2025 18.33%
Jun 29, 2025 16.62%
Mar 30, 2025 -8.47%
Dec 29, 2024 8.11%
Sep 29, 2024 13.17%
Jun 30, 2024 -0.22%
Mar 31, 2024 -2.12%
Dec 31, 2023 3.08%
Oct 1, 2023 8.59%
Jul 2, 2023 -12.50%
Apr 2, 2023 -10.94%
Jan 1, 2023 -4.93%
Oct 2, 2022 -23.84%
Jul 3, 2022 -28.70%
Apr 3, 2022 -25.60%
Jan 2, 2022 -17.10%
Oct 3, 2021 -16.98%
Jul 4, 2021 -11.74%
Apr 4, 2021 -17.43%
Jan 3, 2021 -11.24%
Sep 27, 2020 -23.78%
Jun 28, 2020 -14.18%
Mar 29, 2020 22.91%
Dec 29, 2019 22.79%
Sep 29, 2019 23.72%
Jun 30, 2019 28.94%
Mar 31, 2019 27.27%
Dec 30, 2018 19.95%
Sep 30, 2018 19.63%
Jul 1, 2018 18.86%
Apr 1, 2018 21.41%
Dec 31, 2017 17.92%
Oct 1, 2017 21.07%
Jul 2, 2017 25.93%
Apr 2, 2017 -10.21%
Jan 1, 2017 -12.79%
Oct 2, 2016 -17.03%
Jul 3, 2016 -19.22%
Apr 3, 2016 -22.52%
Jan 3, 2016 -22.09%
Sep 27, 2015 -23.57%
Jun 28, 2015 -26.15%
Mar 29, 2015 2.55%
Dec 28, 2014 -0.85%
Sep 28, 2014 -2.19%
Jun 29, 2014 -2.13%
Mar 30, 2014 -3.04%
Dec 29, 2013 -1.83%
Sep 29, 2013 -4.47%
Jun 30, 2013 -9.96%
Mar 31, 2013 -6.36%
Dec 30, 2012 -3.84%
Sep 30, 2012 -11.31%
Jul 1, 2012 -4.75%
Apr 1, 2012 -39.05%